lifestyle.gamezon.net

Author: Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option

February 20, 2026
Eupraxia Pharmaceuticals Announces Pricing of US$55 Million Public Offering of Common Shares and Pre-Funded Warrants

February 19, 2026
Eupraxia Pharmaceuticals Announces Proposed Public Offering

February 18, 2026